|
AGE
|
AgeX Therapeutics, Inc.
|
US
|
AMEX
|
|
ALLK
|
Allakos Inc.
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALVR
|
AlloVir, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
BLFS
|
BioLife Solutions, Inc.
|
US
|
NASDAQ
|
|
BLI
|
Berkeley Lights, Inc.
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
US
|
NASDAQ
|
|
BPTH
|
Bio-Path Holdings Inc
|
US
|
NASDAQ
|
|
BRTX
|
BioRestorative Therapies, Inc.
|
US
|
NASDAQ
|
|
CBIO
|
Catalyst Inc.
|
US
|
NASDAQ
|
|
CELC
|
Celcuity Inc.
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CTKB
|
Cytek Biosciences, Inc.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
FUSN
|
Fusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|